Estimation of antimicrobial resistance of < em > Mycoplasma genitalium, < /em > Belgium, 2022

ConclusionAlthough limited in sample size, our data suggest no additional benefit of testing MG retrieved from MSM for macrolide resistance in Belgium, when making treatment decisions. The lower occurrence of macrolide resistance in other population groups, combined with emergence of fluoroquinolone RAMs support macrolide-resistance testing in these groups. Continued surveillance of resistance in MG in different population groups will be crucial to confirm our findings and to guide national testing and treatment strategies.PMID:38362626 | DOI:10.2807/1560-7917.ES.2024.29.7.2300318

Source: Euro Surveill - February 16, 2024 Category: Infectious Diseases Authors: Irith De Baetselier Hilde Smet Kaat Kehoe Imelda Loosen Marijke Reynders Iqbal Mansoor Lorenzo Filippin Mathieu Cauchie Ellen Van Even Nadia Makki Gilberte Schiettekatte Wouter Vandewal Bart Glibert Veerle Matheeussen Yolien Van der Beken Reinoud Cartuyve Source Type: research